Ex-Div Reminder For MFS Multi Market Income Trust (MMT)

Looking at the universe of stocks we cover at Dividend Channel, on 4/16/13, MFS Multi Market Income Trust (MMT) will trade ex-dividend, for its monthly dividend of $0.039, payable on 4/30/13. As a percentage of MMT's recent stock price of $7.54, this dividend works out to approximately 0.52%, so look for shares of MFS Multi Market Income Trust to trade 0.52% lower — all else being equal — when MMT shares open for trading on 4/16/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for MMT, showing historical dividends prior to the most recent $0.039 declared by MFS Multi Market Income Trust:

MMT+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from MMT is likely to continue, and whether the current estimated yield of 6.20% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of MMT shares, versus its 200 day moving average:

MFS Multi Market Income Trust 200 Day Moving Average Chart

Looking at the chart above, MMT's low point in its 52 week range is $6.74 per share, with $7.56 as the 52 week high point — that compares with a last trade of $7.54.

In Friday trading, MFS Multi Market Income Trust shares are currently up about 0.3% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says